PTH · Invesco Dorsey Wright Healthcare Momentum ETF ETF
Invesco Exchange-Traded Fund Trust
$61.13
-0.38%
At close · Sep 4
Net assets $120,908,517
Holdings58
1 month
+1.27%
Year to date
+22.99%
52-week range
$39.36–$64.10
30-session avg volume
47,895
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000013104
- Report date
- Apr 30, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | PRAX | $6,142,898 | 5.08% |
| Roivant Sciences Ltd. | ROIV | $5,623,234 | 4.65% |
| United Therapeutics Corp. | UTHR | $4,152,572 | 3.43% |
| Tenet Healthcare Corp. | THC | $3,674,354 | 3.04% |
| Terns Pharmaceuticals, Inc. | 880881107 | $3,459,928 | 2.86% |
| Tango Therapeutics Inc. | TNGX | $3,448,174 | 2.85% |
| HCA Healthcare, Inc. | HCA | $3,357,430 | 2.78% |
| Axsome Therapeutics, Inc. | AXSM | $3,196,234 | 2.64% |
| Nektar Therapeutics | NKTR | $3,109,913 | 2.57% |
| Celcuity Inc. | CELC | $3,055,836 | 2.53% |
| Ionis Pharmaceuticals, Inc. | IONS | $2,870,335 | 2.37% |
| Capricor Therapeutics, Inc. | CAPR | $2,733,479 | 2.26% |
| Cencora, Inc. | COR | $2,719,420 | 2.25% |
| Alumis Inc. | ALMS | $2,564,600 | 2.12% |
| Gilead Sciences, Inc. | GILD | $2,402,615 | 1.99% |
| Kodiak Sciences Inc. | KOD | $2,401,096 | 1.99% |
| BrightSpring Health Services, Inc. | BTSG | $2,390,105 | 1.98% |
| Jazz Pharmaceuticals PLC | JAZZ | $2,319,707 | 1.92% |
| Moderna, Inc. | MRNA | $2,300,675 | 1.90% |
| Protagonist Therapeutics, Inc. | PTGX | $2,292,640 | 1.90% |
| Viatris Inc. | VTRS | $2,271,000 | 1.88% |
| Dianthus Therapeutics, Inc. | DNTH | $2,170,943 | 1.80% |
| AnaptysBio, Inc. | ANAB | $2,149,897 | 1.78% |
| Ensign Group, Inc. (The) | ENSG | $2,095,222 | 1.73% |
| Incyte Corp. | INCY | $2,073,361 | 1.71% |
| Erasca, Inc. | ERAS | $2,067,122 | 1.71% |
| Ligand Pharmaceuticals Inc. | LGND | $1,954,914 | 1.62% |
| Oruka Therapeutics, Inc. | ORKA | $1,937,576 | 1.60% |
| CG Oncology, Inc. | CGON | $1,876,395 | 1.55% |
| Tyra Biosciences, Inc. | TYRA | $1,862,287 | 1.54% |
| SELLAS Life Sciences Group, Inc. | SLS | $1,817,719 | 1.50% |
| Spyre Therapeutics, Inc. | SYRE | $1,795,734 | 1.49% |
| Kymera Therapeutics, Inc. | KYMR | $1,770,163 | 1.46% |
| Twist Bioscience Corp. | TWST | $1,757,241 | 1.45% |
| Liquidia Corp. | LQDA | $1,712,418 | 1.42% |
| Brookdale Senior Living Inc. | BKD | $1,707,734 | 1.41% |
| Axogen, Inc. | AXGN | $1,654,992 | 1.37% |
| Exelixis, Inc. | EXEL | $1,611,719 | 1.33% |
| Edgewise Therapeutics, Inc. | EWTX | $1,585,431 | 1.31% |
| Trevi Therapeutics, Inc. | TRVI | $1,570,209 | 1.30% |
| Cytokinetics, Inc. | CYTK | $1,436,702 | 1.19% |
| Elanco Animal Health Inc. | ELAN | $1,408,214 | 1.16% |
| Relay Therapeutics, Inc. | RLAY | $1,368,239 | 1.13% |
| Dyne Therapeutics, Inc. | DYN | $1,357,633 | 1.12% |
| Vaxcyte, Inc. | PCVX | $1,354,470 | 1.12% |
| Krystal Biotech, Inc. | KRYS | $1,330,445 | 1.10% |
| Enliven Therapeutics, Inc. | ELVN | $1,292,272 | 1.07% |
| Arcus Biosciences, Inc. | RCUS | $1,139,468 | 0.94% |
| Annexon, Inc. | ANNX | $1,109,025 | 0.92% |
| Stoke Therapeutics, Inc. | STOK | $1,103,155 | 0.91% |